P156 Submucosa hypertrophy of active UC patients suggests transmural involvement in UC-associated inflammation Article Swipe
Torsten Kucharzik
,
Ulf Helwig
,
Deike Strobel
,
Imma Fischer
,
L Hammer
,
Stefan Rath
,
Christian Maaser
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1093/ecco-jcc/jjac190.0286
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1093/ecco-jcc/jjac190.0286
Background Transmural response and healing assessed by intestinal ultrasound (IUS) have gained relevance as outcome measures with the ability to guide treatment decisions in inflammatory bowel diseases (IBD). Bowel wall thickness (BWT) is the most widely used IUS parameter and encompasses the thickness of mucosa, muscularis mucosae, and submucosa [1]. Recently, the ratio between submucosa/BWT to estimate endoscopic remission was suggested [2] and de Voogd et al. have shown that the submucosa is the most responsive wall layer [3]. However, little is known about the association between submucosa hypertrophy and clinical as well as lab parameters. Methods TRUST&UC was a prospective, observational study including 224 UC patients with increased BWT at baseline and active disease (SCCAI ≥ 5) with up to 4 visits (baseline, optional visit at week 2 (W2), W6 and W12). At baseline, patients received therapy intensification according to standard of care. In this post-hoc analysis, 171 patients with a W12 visit ± 4 weeks were included. Overall BWT, mucosa and submucosa thickness were evaluated for the sigmoid colon and stratified for SCCAI, CRP, fecal calprotectin (fCal), and Mayo endoscopic subscore (MES). Results Active UC patients in our cohort had a median age and disease duration of 37.1 years (28.9 –50.2) and 3.55 years (0.54 – 10.18), more were male (56.6%, n = 95). At baseline, UC patients presented with a high disease activity reflected by a median SCCAI of 9.00 (7.0-10.0). Mean values for BWT, mucosa, and submucosa were 5.54 mm, 1.7 mm, and 2.32 mm, respectively. Over the study course, mucosa and submucosa thickness were significantly reduced with the most pronounced reduction happening within the first 2 weeks (figure 1). Patients with SCCAI ≤ 2 tended to have a more reduced mucosa and submucosa thickness than patients with SCCAI > 2 (fig 2A, A1). Whilst a similar trend was observed for fCal values (not shown), this effect was found neither for CRP (not shown) nor for MES. Conclusion We found that both mucosa and submucosa thickness of active UC patients were reduced as a consequence of therapy intensification. The lack of difference in thickness of both mucosa and submucosa in patients with and without MES improvement might indicate fibrotic alterations in these patients which needs further evaluation. Based on these and previous results of our group, we suggest measuring BWT in conjunction with other established IUS parameters such as colour Doppler signal to assess disease activity in UC. 1-Ilvermark et al. JCC 2022 2-Miyoshi et al. J Gastroenterol 2022 3-de Voogd et al. Gastroenterol 2022
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1093/ecco-jcc/jjac190.0286
- https://academic.oup.com/ecco-jcc/article-pdf/17/Supplement_1/i316/48952542/jjac190.0286.pdf
- OA Status
- bronze
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4318576028
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4318576028Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1093/ecco-jcc/jjac190.0286Digital Object Identifier
- Title
-
P156 Submucosa hypertrophy of active UC patients suggests transmural involvement in UC-associated inflammationWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-01-30Full publication date if available
- Authors
-
Torsten Kucharzik, Ulf Helwig, Deike Strobel, Imma Fischer, L Hammer, Stefan Rath, Christian MaaserList of authors in order
- Landing page
-
https://doi.org/10.1093/ecco-jcc/jjac190.0286Publisher landing page
- PDF URL
-
https://academic.oup.com/ecco-jcc/article-pdf/17/Supplement_1/i316/48952542/jjac190.0286.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://academic.oup.com/ecco-jcc/article-pdf/17/Supplement_1/i316/48952542/jjac190.0286.pdfDirect OA link when available
- Concepts
-
Submucosa, Medicine, Internal medicine, Muscularis mucosae, Gastroenterology, Intestinal mucosa, Prospective cohort studyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4318576028 |
|---|---|
| doi | https://doi.org/10.1093/ecco-jcc/jjac190.0286 |
| ids.doi | https://doi.org/10.1093/ecco-jcc/jjac190.0286 |
| ids.openalex | https://openalex.org/W4318576028 |
| fwci | 0.0 |
| type | article |
| title | P156 Submucosa hypertrophy of active UC patients suggests transmural involvement in UC-associated inflammation |
| biblio.issue | Supplement_1 |
| biblio.volume | 17 |
| biblio.last_page | i316 |
| biblio.first_page | i316 |
| topics[0].id | https://openalex.org/T10696 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.998199999332428 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2740 |
| topics[0].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[0].display_name | Gastric Cancer Management and Outcomes |
| topics[1].id | https://openalex.org/T10134 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9980999827384949 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1311 |
| topics[1].subfield.display_name | Genetics |
| topics[1].display_name | Inflammatory Bowel Disease |
| topics[2].id | https://openalex.org/T10276 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9980000257492065 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2746 |
| topics[2].subfield.display_name | Surgery |
| topics[2].display_name | Helicobacter pylori-related gastroenterology studies |
| is_xpac | False |
| apc_list.value | 3881 |
| apc_list.currency | EUR |
| apc_list.value_usd | 4185 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2779052585 |
| concepts[0].level | 2 |
| concepts[0].score | 0.9635270833969116 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q1760245 |
| concepts[0].display_name | Submucosa |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.8204962611198425 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C126322002 |
| concepts[2].level | 1 |
| concepts[2].score | 0.6356287002563477 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[2].display_name | Internal medicine |
| concepts[3].id | https://openalex.org/C2777960253 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6201755404472351 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q6133133 |
| concepts[3].display_name | Muscularis mucosae |
| concepts[4].id | https://openalex.org/C90924648 |
| concepts[4].level | 1 |
| concepts[4].score | 0.6061232686042786 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q120569 |
| concepts[4].display_name | Gastroenterology |
| concepts[5].id | https://openalex.org/C3019368612 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4477071762084961 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q17154506 |
| concepts[5].display_name | Intestinal mucosa |
| concepts[6].id | https://openalex.org/C188816634 |
| concepts[6].level | 2 |
| concepts[6].score | 0.4372442960739136 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q2113324 |
| concepts[6].display_name | Prospective cohort study |
| keywords[0].id | https://openalex.org/keywords/submucosa |
| keywords[0].score | 0.9635270833969116 |
| keywords[0].display_name | Submucosa |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.8204962611198425 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/internal-medicine |
| keywords[2].score | 0.6356287002563477 |
| keywords[2].display_name | Internal medicine |
| keywords[3].id | https://openalex.org/keywords/muscularis-mucosae |
| keywords[3].score | 0.6201755404472351 |
| keywords[3].display_name | Muscularis mucosae |
| keywords[4].id | https://openalex.org/keywords/gastroenterology |
| keywords[4].score | 0.6061232686042786 |
| keywords[4].display_name | Gastroenterology |
| keywords[5].id | https://openalex.org/keywords/intestinal-mucosa |
| keywords[5].score | 0.4477071762084961 |
| keywords[5].display_name | Intestinal mucosa |
| keywords[6].id | https://openalex.org/keywords/prospective-cohort-study |
| keywords[6].score | 0.4372442960739136 |
| keywords[6].display_name | Prospective cohort study |
| language | en |
| locations[0].id | doi:10.1093/ecco-jcc/jjac190.0286 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2735960814 |
| locations[0].source.issn | 1873-9946, 1876-4479 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1873-9946 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Journal of Crohn s and Colitis |
| locations[0].source.host_organization | https://openalex.org/P4310311648 |
| locations[0].source.host_organization_name | Oxford University Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310311648 |
| locations[0].license | |
| locations[0].pdf_url | https://academic.oup.com/ecco-jcc/article-pdf/17/Supplement_1/i316/48952542/jjac190.0286.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of Crohn's and Colitis |
| locations[0].landing_page_url | https://doi.org/10.1093/ecco-jcc/jjac190.0286 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5033555498 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-0183-4483 |
| authorships[0].author.display_name | Torsten Kucharzik |
| authorships[0].countries | DE |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210117663 |
| authorships[0].affiliations[0].raw_affiliation_string | University Teaching Hospital Lueneburg, Department of Internal Medicine and Gastroenterology , Lueneburg, Germany |
| authorships[0].institutions[0].id | https://openalex.org/I4210117663 |
| authorships[0].institutions[0].ror | https://ror.org/02k57ty04 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210117663 |
| authorships[0].institutions[0].country_code | DE |
| authorships[0].institutions[0].display_name | Klinikum Lüneburg |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | T Kucharzik |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | University Teaching Hospital Lueneburg, Department of Internal Medicine and Gastroenterology , Lueneburg, Germany |
| authorships[1].author.id | https://openalex.org/A5040465224 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-6205-7633 |
| authorships[1].author.display_name | Ulf Helwig |
| authorships[1].countries | DE |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I32021983 |
| authorships[1].affiliations[0].raw_affiliation_string | Christian- Albrechts University of Kiel, Christian- Albrechts University of Kiel , Kiel, Germany |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I4210108766 |
| authorships[1].affiliations[1].raw_affiliation_string | Gastroenterology Practice, Gastroenterology Practice , Oldenburg, Germany |
| authorships[1].institutions[0].id | https://openalex.org/I32021983 |
| authorships[1].institutions[0].ror | https://ror.org/04v76ef78 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I32021983 |
| authorships[1].institutions[0].country_code | DE |
| authorships[1].institutions[0].display_name | Christian-Albrechts-Universität zu Kiel |
| authorships[1].institutions[1].id | https://openalex.org/I4210108766 |
| authorships[1].institutions[1].ror | https://ror.org/01t0n2c80 |
| authorships[1].institutions[1].type | healthcare |
| authorships[1].institutions[1].lineage | https://openalex.org/I4210108766 |
| authorships[1].institutions[1].country_code | DE |
| authorships[1].institutions[1].display_name | Klinikum Oldenburg |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | U Helwig |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Christian- Albrechts University of Kiel, Christian- Albrechts University of Kiel , Kiel, Germany, Gastroenterology Practice, Gastroenterology Practice , Oldenburg, Germany |
| authorships[2].author.id | https://openalex.org/A5061628558 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-6144-0710 |
| authorships[2].author.display_name | Deike Strobel |
| authorships[2].countries | DE |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210088053 |
| authorships[2].affiliations[0].raw_affiliation_string | University hospital Erlangen, Medicine 1 , Erlangen, Germany |
| authorships[2].institutions[0].id | https://openalex.org/I4210088053 |
| authorships[2].institutions[0].ror | https://ror.org/0030f2a11 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210088053 |
| authorships[2].institutions[0].country_code | DE |
| authorships[2].institutions[0].display_name | Universitätsklinikum Erlangen |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | D Strobel |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | University hospital Erlangen, Medicine 1 , Erlangen, Germany |
| authorships[3].author.id | https://openalex.org/A5111729022 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Imma Fischer |
| authorships[3].countries | DE |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I8087733 |
| authorships[3].affiliations[0].raw_affiliation_string | Biostatistik Tuebingen, Biostatistik Tuebingen , Tuebingen, Germany |
| authorships[3].institutions[0].id | https://openalex.org/I8087733 |
| authorships[3].institutions[0].ror | https://ror.org/03a1kwz48 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I8087733 |
| authorships[3].institutions[0].country_code | DE |
| authorships[3].institutions[0].display_name | University of Tübingen |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | I Fischer |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Biostatistik Tuebingen, Biostatistik Tuebingen , Tuebingen, Germany |
| authorships[4].author.id | https://openalex.org/A5036365997 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-2606-6337 |
| authorships[4].author.display_name | L Hammer |
| authorships[4].countries | DE |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210128201 |
| authorships[4].affiliations[0].raw_affiliation_string | AbbVie Deutschland GmbH & Co. KG, Medical Department Gastroenterology , Wiesbaden, Germany |
| authorships[4].institutions[0].id | https://openalex.org/I4210128201 |
| authorships[4].institutions[0].ror | https://ror.org/03538jp08 |
| authorships[4].institutions[0].type | company |
| authorships[4].institutions[0].lineage | https://openalex.org/I2948539688, https://openalex.org/I4210128201 |
| authorships[4].institutions[0].country_code | DE |
| authorships[4].institutions[0].display_name | AbbVie (Germany) |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | L Hammer |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | AbbVie Deutschland GmbH & Co. KG, Medical Department Gastroenterology , Wiesbaden, Germany |
| authorships[5].author.id | https://openalex.org/A5084179179 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-0265-0923 |
| authorships[5].author.display_name | Stefan Rath |
| authorships[5].countries | DE |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210128201 |
| authorships[5].affiliations[0].raw_affiliation_string | AbbVie Germany GmbH & Co. KG, Medical Department Gastroenterology , Wiesbaden, Germany |
| authorships[5].institutions[0].id | https://openalex.org/I4210128201 |
| authorships[5].institutions[0].ror | https://ror.org/03538jp08 |
| authorships[5].institutions[0].type | company |
| authorships[5].institutions[0].lineage | https://openalex.org/I2948539688, https://openalex.org/I4210128201 |
| authorships[5].institutions[0].country_code | DE |
| authorships[5].institutions[0].display_name | AbbVie (Germany) |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | S Rath |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | AbbVie Germany GmbH & Co. KG, Medical Department Gastroenterology , Wiesbaden, Germany |
| authorships[6].author.id | https://openalex.org/A5028859025 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-3889-405X |
| authorships[6].author.display_name | Christian Maaser |
| authorships[6].countries | DE |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210117663 |
| authorships[6].affiliations[0].raw_affiliation_string | University Teaching Hospital Lueneburg, Outpatients department Gastroenterology , Lueneburg, Germany |
| authorships[6].institutions[0].id | https://openalex.org/I4210117663 |
| authorships[6].institutions[0].ror | https://ror.org/02k57ty04 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210117663 |
| authorships[6].institutions[0].country_code | DE |
| authorships[6].institutions[0].display_name | Klinikum Lüneburg |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | C Maaser |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | University Teaching Hospital Lueneburg, Outpatients department Gastroenterology , Lueneburg, Germany |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://academic.oup.com/ecco-jcc/article-pdf/17/Supplement_1/i316/48952542/jjac190.0286.pdf |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | P156 Submucosa hypertrophy of active UC patients suggests transmural involvement in UC-associated inflammation |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10696 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.998199999332428 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2740 |
| primary_topic.subfield.display_name | Pulmonary and Respiratory Medicine |
| primary_topic.display_name | Gastric Cancer Management and Outcomes |
| related_works | https://openalex.org/W2141178158, https://openalex.org/W2808288384, https://openalex.org/W2011572455, https://openalex.org/W1892649470, https://openalex.org/W2136958054, https://openalex.org/W2563443183, https://openalex.org/W4306949359, https://openalex.org/W2596513556, https://openalex.org/W4319597582, https://openalex.org/W2038674599 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1093/ecco-jcc/jjac190.0286 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2735960814 |
| best_oa_location.source.issn | 1873-9946, 1876-4479 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1873-9946 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Journal of Crohn s and Colitis |
| best_oa_location.source.host_organization | https://openalex.org/P4310311648 |
| best_oa_location.source.host_organization_name | Oxford University Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310311648 |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://academic.oup.com/ecco-jcc/article-pdf/17/Supplement_1/i316/48952542/jjac190.0286.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of Crohn's and Colitis |
| best_oa_location.landing_page_url | https://doi.org/10.1093/ecco-jcc/jjac190.0286 |
| primary_location.id | doi:10.1093/ecco-jcc/jjac190.0286 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2735960814 |
| primary_location.source.issn | 1873-9946, 1876-4479 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1873-9946 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Journal of Crohn s and Colitis |
| primary_location.source.host_organization | https://openalex.org/P4310311648 |
| primary_location.source.host_organization_name | Oxford University Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310311648 |
| primary_location.license | |
| primary_location.pdf_url | https://academic.oup.com/ecco-jcc/article-pdf/17/Supplement_1/i316/48952542/jjac190.0286.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of Crohn's and Colitis |
| primary_location.landing_page_url | https://doi.org/10.1093/ecco-jcc/jjac190.0286 |
| publication_date | 2023-01-30 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.2 | 129, 271, 279, 295 |
| abstract_inverted_index.4 | 122, 156 |
| abstract_inverted_index.= | 215 |
| abstract_inverted_index.J | 411 |
| abstract_inverted_index.a | 100, 152, 193, 223, 229, 283, 300, 338 |
| abstract_inverted_index.n | 214 |
| abstract_inverted_index.5) | 118 |
| abstract_inverted_index.At | 134, 217 |
| abstract_inverted_index.In | 145 |
| abstract_inverted_index.UC | 106, 187, 219, 333 |
| abstract_inverted_index.W6 | 131 |
| abstract_inverted_index.We | 323 |
| abstract_inverted_index.as | 14, 92, 94, 337, 393 |
| abstract_inverted_index.at | 111, 127 |
| abstract_inverted_index.by | 7, 228 |
| abstract_inverted_index.de | 64 |
| abstract_inverted_index.et | 66, 404, 409, 416 |
| abstract_inverted_index.in | 24, 189, 347, 354, 365, 385, 401 |
| abstract_inverted_index.is | 33, 73, 82 |
| abstract_inverted_index.of | 44, 143, 199, 232, 331, 340, 345, 349, 378 |
| abstract_inverted_index.on | 373 |
| abstract_inverted_index.to | 20, 56, 121, 141, 281, 397 |
| abstract_inverted_index.up | 120 |
| abstract_inverted_index.we | 381 |
| abstract_inverted_index.± | 155 |
| abstract_inverted_index.1). | 274 |
| abstract_inverted_index.1.7 | 245 |
| abstract_inverted_index.171 | 149 |
| abstract_inverted_index.224 | 105 |
| abstract_inverted_index.2A, | 297 |
| abstract_inverted_index.BWT | 110, 384 |
| abstract_inverted_index.CRP | 316 |
| abstract_inverted_index.IUS | 38, 390 |
| abstract_inverted_index.JCC | 406 |
| abstract_inverted_index.MES | 359 |
| abstract_inverted_index.The | 343 |
| abstract_inverted_index.UC. | 402 |
| abstract_inverted_index.W12 | 153 |
| abstract_inverted_index.[2] | 62 |
| abstract_inverted_index.age | 195 |
| abstract_inverted_index.al. | 67, 405, 410, 417 |
| abstract_inverted_index.and | 4, 40, 48, 63, 90, 113, 132, 163, 172, 180, 196, 204, 240, 247, 256, 287, 328, 352, 357, 375 |
| abstract_inverted_index.for | 168, 174, 237, 305, 315, 320 |
| abstract_inverted_index.had | 192 |
| abstract_inverted_index.lab | 95 |
| abstract_inverted_index.mm, | 244, 246, 249 |
| abstract_inverted_index.nor | 319 |
| abstract_inverted_index.our | 190, 379 |
| abstract_inverted_index.the | 18, 34, 42, 52, 71, 74, 85, 169, 252, 263, 269 |
| abstract_inverted_index.was | 60, 99, 303, 312 |
| abstract_inverted_index.– | 208 |
| abstract_inverted_index.≤ | 278 |
| abstract_inverted_index.≥ | 117 |
| abstract_inverted_index.(fig | 296 |
| abstract_inverted_index.(not | 308, 317 |
| abstract_inverted_index.2.32 | 248 |
| abstract_inverted_index.2022 | 407, 413, 419 |
| abstract_inverted_index.3-de | 414 |
| abstract_inverted_index.3.55 | 205 |
| abstract_inverted_index.37.1 | 200 |
| abstract_inverted_index.5.54 | 243 |
| abstract_inverted_index.9.00 | 233 |
| abstract_inverted_index.95). | 216 |
| abstract_inverted_index.A1). | 298 |
| abstract_inverted_index.BWT, | 161, 238 |
| abstract_inverted_index.CRP, | 176 |
| abstract_inverted_index.MES. | 321 |
| abstract_inverted_index.Mayo | 181 |
| abstract_inverted_index.Mean | 235 |
| abstract_inverted_index.Over | 251 |
| abstract_inverted_index.[1]. | 50 |
| abstract_inverted_index.[3]. | 79 |
| abstract_inverted_index.both | 326, 350 |
| abstract_inverted_index.fCal | 306 |
| abstract_inverted_index.have | 11, 68, 282 |
| abstract_inverted_index.high | 224 |
| abstract_inverted_index.lack | 344 |
| abstract_inverted_index.male | 212 |
| abstract_inverted_index.more | 210, 284 |
| abstract_inverted_index.most | 35, 75, 264 |
| abstract_inverted_index.such | 392 |
| abstract_inverted_index.than | 290 |
| abstract_inverted_index.that | 70, 325 |
| abstract_inverted_index.this | 146, 310 |
| abstract_inverted_index.used | 37 |
| abstract_inverted_index.wall | 30, 77 |
| abstract_inverted_index.week | 128 |
| abstract_inverted_index.well | 93 |
| abstract_inverted_index.were | 158, 166, 211, 242, 259, 335 |
| abstract_inverted_index.with | 17, 108, 119, 151, 222, 262, 276, 292, 356, 387 |
| abstract_inverted_index.(0.54 | 207 |
| abstract_inverted_index.(28.9 | 202 |
| abstract_inverted_index.(BWT) | 32 |
| abstract_inverted_index.(IUS) | 10 |
| abstract_inverted_index.(W2), | 130 |
| abstract_inverted_index.Based | 372 |
| abstract_inverted_index.Bowel | 29 |
| abstract_inverted_index.SCCAI | 231, 277, 293 |
| abstract_inverted_index.Voogd | 65, 415 |
| abstract_inverted_index.W12). | 133 |
| abstract_inverted_index.about | 84 |
| abstract_inverted_index.bowel | 26 |
| abstract_inverted_index.care. | 144 |
| abstract_inverted_index.colon | 171 |
| abstract_inverted_index.fecal | 177 |
| abstract_inverted_index.first | 270 |
| abstract_inverted_index.found | 313, 324 |
| abstract_inverted_index.guide | 21 |
| abstract_inverted_index.known | 83 |
| abstract_inverted_index.layer | 78 |
| abstract_inverted_index.might | 361 |
| abstract_inverted_index.needs | 369 |
| abstract_inverted_index.other | 388 |
| abstract_inverted_index.ratio | 53 |
| abstract_inverted_index.shown | 69 |
| abstract_inverted_index.study | 103, 253 |
| abstract_inverted_index.these | 366, 374 |
| abstract_inverted_index.trend | 302 |
| abstract_inverted_index.visit | 126, 154 |
| abstract_inverted_index.weeks | 157, 272 |
| abstract_inverted_index.which | 368 |
| abstract_inverted_index.years | 201, 206 |
| abstract_inverted_index.(IBD). | 28 |
| abstract_inverted_index.(MES). | 184 |
| abstract_inverted_index.(SCCAI | 116 |
| abstract_inverted_index.Active | 186 |
| abstract_inverted_index.SCCAI, | 175 |
| abstract_inverted_index.Whilst | 299 |
| abstract_inverted_index.active | 114, 332 |
| abstract_inverted_index.assess | 398 |
| abstract_inverted_index.cohort | 191 |
| abstract_inverted_index.colour | 394 |
| abstract_inverted_index.effect | 311 |
| abstract_inverted_index.gained | 12 |
| abstract_inverted_index.group, | 380 |
| abstract_inverted_index.little | 81 |
| abstract_inverted_index.median | 194, 230 |
| abstract_inverted_index.mucosa | 162, 255, 286, 327, 351 |
| abstract_inverted_index.shown) | 318 |
| abstract_inverted_index.signal | 396 |
| abstract_inverted_index.tended | 280 |
| abstract_inverted_index.values | 236, 307 |
| abstract_inverted_index.visits | 123 |
| abstract_inverted_index.widely | 36 |
| abstract_inverted_index.within | 268 |
| abstract_inverted_index.(56.6%, | 213 |
| abstract_inverted_index.(fCal), | 179 |
| abstract_inverted_index.(figure | 273 |
| abstract_inverted_index.10.18), | 209 |
| abstract_inverted_index.Doppler | 395 |
| abstract_inverted_index.Methods | 97 |
| abstract_inverted_index.Overall | 160 |
| abstract_inverted_index.Results | 185 |
| abstract_inverted_index.ability | 19 |
| abstract_inverted_index.between | 54, 87 |
| abstract_inverted_index.course, | 254 |
| abstract_inverted_index.disease | 115, 197, 225, 399 |
| abstract_inverted_index.further | 370 |
| abstract_inverted_index.healing | 5 |
| abstract_inverted_index.mucosa, | 45, 239 |
| abstract_inverted_index.neither | 314 |
| abstract_inverted_index.outcome | 15 |
| abstract_inverted_index.reduced | 261, 285, 336 |
| abstract_inverted_index.results | 377 |
| abstract_inverted_index.shown), | 309 |
| abstract_inverted_index.sigmoid | 170 |
| abstract_inverted_index.similar | 301 |
| abstract_inverted_index.suggest | 382 |
| abstract_inverted_index.therapy | 138, 341 |
| abstract_inverted_index.without | 358 |
| abstract_inverted_index.> | 294 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.However, | 80 |
| abstract_inverted_index.Patients | 275 |
| abstract_inverted_index.activity | 226, 400 |
| abstract_inverted_index.assessed | 6 |
| abstract_inverted_index.baseline | 112 |
| abstract_inverted_index.clinical | 91 |
| abstract_inverted_index.diseases | 27 |
| abstract_inverted_index.duration | 198 |
| abstract_inverted_index.estimate | 57 |
| abstract_inverted_index.fibrotic | 363 |
| abstract_inverted_index.indicate | 362 |
| abstract_inverted_index.measures | 16 |
| abstract_inverted_index.mucosae, | 47 |
| abstract_inverted_index.observed | 304 |
| abstract_inverted_index.optional | 125 |
| abstract_inverted_index.patients | 107, 136, 150, 188, 220, 291, 334, 355, 367 |
| abstract_inverted_index.post-hoc | 147 |
| abstract_inverted_index.previous | 376 |
| abstract_inverted_index.received | 137 |
| abstract_inverted_index.response | 3 |
| abstract_inverted_index.standard | 142 |
| abstract_inverted_index.subscore | 183 |
| abstract_inverted_index.–50.2) | 203 |
| abstract_inverted_index.2-Miyoshi | 408 |
| abstract_inverted_index.Recently, | 51 |
| abstract_inverted_index.according | 140 |
| abstract_inverted_index.analysis, | 148 |
| abstract_inverted_index.baseline, | 135, 218 |
| abstract_inverted_index.decisions | 23 |
| abstract_inverted_index.evaluated | 167 |
| abstract_inverted_index.happening | 267 |
| abstract_inverted_index.included. | 159 |
| abstract_inverted_index.including | 104 |
| abstract_inverted_index.increased | 109 |
| abstract_inverted_index.measuring | 383 |
| abstract_inverted_index.parameter | 39 |
| abstract_inverted_index.presented | 221 |
| abstract_inverted_index.reduction | 266 |
| abstract_inverted_index.reflected | 227 |
| abstract_inverted_index.relevance | 13 |
| abstract_inverted_index.remission | 59 |
| abstract_inverted_index.submucosa | 49, 72, 88, 164, 241, 257, 288, 329, 353 |
| abstract_inverted_index.suggested | 61 |
| abstract_inverted_index.thickness | 31, 43, 165, 258, 289, 330, 348 |
| abstract_inverted_index.treatment | 22 |
| abstract_inverted_index.(baseline, | 124 |
| abstract_inverted_index.Background | 1 |
| abstract_inverted_index.Conclusion | 322 |
| abstract_inverted_index.Transmural | 2 |
| abstract_inverted_index.difference | 346 |
| abstract_inverted_index.endoscopic | 58, 182 |
| abstract_inverted_index.intestinal | 8 |
| abstract_inverted_index.muscularis | 46 |
| abstract_inverted_index.parameters | 391 |
| abstract_inverted_index.pronounced | 265 |
| abstract_inverted_index.responsive | 76 |
| abstract_inverted_index.stratified | 173 |
| abstract_inverted_index.ultrasound | 9 |
| abstract_inverted_index.(7.0-10.0). | 234 |
| abstract_inverted_index.1-Ilvermark | 403 |
| abstract_inverted_index.alterations | 364 |
| abstract_inverted_index.association | 86 |
| abstract_inverted_index.conjunction | 386 |
| abstract_inverted_index.consequence | 339 |
| abstract_inverted_index.encompasses | 41 |
| abstract_inverted_index.established | 389 |
| abstract_inverted_index.evaluation. | 371 |
| abstract_inverted_index.hypertrophy | 89 |
| abstract_inverted_index.improvement | 360 |
| abstract_inverted_index.parameters. | 96 |
| abstract_inverted_index.TRUST&UC | 98 |
| abstract_inverted_index.calprotectin | 178 |
| abstract_inverted_index.inflammatory | 25 |
| abstract_inverted_index.prospective, | 101 |
| abstract_inverted_index.Gastroenterol | 412, 418 |
| abstract_inverted_index.observational | 102 |
| abstract_inverted_index.respectively. | 250 |
| abstract_inverted_index.significantly | 260 |
| abstract_inverted_index.submucosa/BWT | 55 |
| abstract_inverted_index.intensification | 139 |
| abstract_inverted_index.intensification. | 342 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 7 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7799999713897705 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.01354675 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |